Ubs Asset Management Americas Inc Insmed Inc Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Insmed Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 512,749 shares of INSM stock, worth $99.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
512,749
Previous 695,961 26.33%
Holding current value
$99.1 Million
Previous $70 Million 5.42%
% of portfolio
0.02%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$96.14 - $147.2 $17.6 Million - $27 Million
-183,212 Reduced 26.33%
512,749 $73.8 Million
Q2 2025

Aug 14, 2025
BUY
$64.81 - $105.9 $10.1 Million - $16.6 Million
156,477 Added 29.0%
695,961 $70 Million
Q1 2025

May 19, 2025
BUY
$65.25 - $83.83 $3.43 Million - $4.41 Million
52,637 Added 10.81%
539,484 $41.2 Million
Q4 2024

Feb 14, 2025
BUY
$66.29 - $76.63 $4.24 Million - $4.9 Million
63,911 Added 15.11%
486,847 $33.6 Million
Q3 2024

Nov 14, 2024
SELL
$62.0 - $79.01 $887,778 - $1.13 Million
-14,319 Reduced 3.27%
422,936 $30.9 Million
Q2 2024

Aug 13, 2024
BUY
$22.0 - $69.71 $665,060 - $2.11 Million
30,230 Added 7.43%
437,255 $29.3 Million
Q1 2024

May 15, 2024
SELL
$25.72 - $29.94 $14,017 - $16,317
-545 Reduced 0.13%
407,025 $11 Million
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $1.03 Million - $1.39 Million
43,940 Added 12.08%
407,570 $12.6 Million
Q3 2023

Nov 13, 2023
BUY
$19.86 - $26.93 $215,917 - $292,782
10,872 Added 3.08%
363,630 $9.18 Million
Q1 2023

May 15, 2023
SELL
$16.26 - $21.73 $42,519 - $56,823
-2,615 Reduced 0.74%
352,758 $6.01 Million
Q4 2022

Feb 14, 2023
BUY
$16.98 - $23.15 $454,096 - $619,100
26,743 Added 8.14%
355,373 $7.1 Million
Q3 2022

Nov 14, 2022
SELL
$20.88 - $28.21 $2.56 Million - $3.47 Million
-122,837 Reduced 27.21%
328,630 $7.08 Million
Q2 2022

Aug 12, 2022
SELL
$17.07 - $25.71 $127,820 - $192,516
-7,488 Reduced 1.63%
451,467 $8.9 Million
Q1 2022

May 16, 2022
BUY
$20.42 - $28.13 $6.74 Million - $9.28 Million
330,065 Added 256.08%
458,955 $10.8 Million
Q4 2021

Feb 14, 2022
BUY
$25.89 - $33.45 $349,256 - $451,240
13,490 Added 11.69%
128,890 $3.51 Million
Q3 2021

Nov 15, 2021
SELL
$22.46 - $29.47 $170,696 - $223,972
-7,600 Reduced 6.18%
115,400 $3.18 Million
Q2 2021

Aug 16, 2021
BUY
$24.17 - $36.01 $159,425 - $237,521
6,596 Added 5.67%
123,000 $3.5 Million
Q1 2021

May 14, 2021
BUY
$32.28 - $44.3 $80,732 - $110,794
2,501 Added 2.2%
116,404 $3.96 Million
Q4 2020

Mar 01, 2021
BUY
$31.45 - $40.54 $322,897 - $416,224
10,267 Added 9.91%
113,903 $3.79 Million
Q3 2020

Nov 13, 2020
SELL
$26.0 - $34.5 $56,290 - $74,692
-2,165 Reduced 2.05%
103,636 $3.33 Million
Q2 2020

Aug 14, 2020
BUY
$14.11 - $29.42 $79,622 - $166,017
5,643 Added 5.63%
105,801 $2.91 Million
Q1 2020

May 15, 2020
BUY
$13.63 - $33.98 $140,184 - $349,484
10,285 Added 11.44%
100,158 $1.61 Million
Q4 2019

Feb 14, 2020
BUY
$16.12 - $24.98 $25,485 - $39,493
1,581 Added 1.79%
89,873 $2.15 Million
Q3 2019

Nov 14, 2019
BUY
$15.49 - $25.78 $232,830 - $387,499
15,031 Added 20.52%
88,292 $1.56 Million
Q2 2019

Aug 15, 2019
BUY
$23.0 - $32.19 $612,398 - $857,090
26,626 Added 57.09%
73,261 $0
Q1 2019

May 14, 2019
BUY
$13.91 - $31.15 $96,187 - $215,402
6,915 Added 17.41%
46,635 $0
Q4 2018

Feb 13, 2019
SELL
$11.6 - $18.7 $117,194 - $188,926
-10,103 Reduced 20.28%
39,720 $521,000
Q3 2018

Nov 14, 2018
SELL
$18.95 - $28.08 $4,604 - $6,823
-243 Reduced 0.49%
49,823 $0
Q2 2018

Aug 14, 2018
SELL
$20.0 - $29.72 $68,760 - $102,177
-3,438 Reduced 6.43%
50,066 $0
Q1 2018

May 14, 2018
BUY
$21.69 - $32.99 $164,084 - $249,569
7,565 Added 16.47%
53,504 $0
Q4 2017

Feb 09, 2018
BUY
$26.43 - $31.78 $537,691 - $646,532
20,344 Added 79.48%
45,939 $0
Q3 2017

Nov 13, 2017
BUY
$11.61 - $31.21 $297,157 - $798,819
25,595
25,595 $0

Others Institutions Holding INSM

# of Institutions
644
Shares Held
208M
Call Options Held
3.83M
Put Options Held
4.26M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email